Mass

Otterbourg P.C. Launches Mass Tort Bankruptcy Practice Group to Navigate Complex Cases

by

New York City, NY – Otterbourg P.C. has officially announced the launch of its Mass Tort Bankruptcy Practice Group. The group, which had previously functioned informally within the firm, has now solidified its position as a key practice area. The practice group will offer guidance and representation to creditors and fiduciaries involved in bankruptcies with substantial mass tort liabilities. Led by Bankruptcy and Restructuring Partner Sunni P. Beville and Litigation Partner Adam C. Silverstein, the cross-departmental practice group will benefit from the expertise of Melanie Cyganowski, retired Chief Judge of the Bankruptcy Court for the … Read more

Surge of Lawsuits Emerges as Mass Torts Target 3M and J&J in 2023, Shaking Up Legal Landscape

by

Atlanta, GA – The number of new federal lawsuits reached a significant increase in 2023, largely due to the surge in mass tort cases against 3M and Johnson & Johnson. These corporations have been in the spotlight recently for their alleged involvement in manufacturing defective products. The rise in litigation against 3M and Johnson & Johnson has led to a flood of new lawsuits across the country. Plaintiffs are seeking compensation for a variety of issues, including health problems caused by faulty medical devices, contaminated products, and dangerous drugs. As a result, federal courts have … Read more

Groundbreaking Resolution Reached as Philadelphia Mass Tort Case Against Janssen’s Bladder Drug Concludes Successfully

by

PHILADELPHIA, PA – A mass tort case against pharmaceutical company Janssen over its bladder drug is coming to a close without a jury verdict. The trial had begun in late October with sixty-two plaintiffs alleging that Janssen’s drug had caused them harm. However, the case was recently settled for an undisclosed amount, marking the end of the litigation. The lawsuit was filed in the Philadelphia Court of Common Pleas, where thousands of other lawsuits related to the drug have been consolidated as part of a mass tort program. The plaintiffs claimed that Janssen failed to … Read more

Philadelphia Mass Tort Over Bladder Drug Concludes Without Bellwether Trial, Confidential Settlements Reached

by

Philadelphia’s coordinated litigation over bladder medication Elmiron is coming to a close. The mass tort had its first trial scheduled to begin on Monday, but the majority of cases have been resolved through confidential settlements in the past six months. Tobi Millrood, partner at Kline & Specter and plaintiffs liaison counsel, provided this information. The Philadelphia mass tort involved numerous cases related to the use of Elmiron, a bladder medication. Confidential settlements have been reached for most of the cases in the program, leading to the cancellation of the bellwether trial. This trial would have … Read more